Lack of functional selectin ligand interactions compromises long term tumor protection by CD8 + T cells

Central memory CD8 + T cells expressing the adhesion molecule CD62L (L-selectin) are potent mediators of anti-cancer immunity due to their ability to proliferate extensively upon antigen re-stimulation. The interaction of selectin with its ligands mediates leukocyte rolling along high endothelial venules. Mice deficient in \u3b1(1,3) Fucosyltransferase IV and VII (FtDKO) lack functional L, P and E selectin ligands. Thus, we addressed whether the lack of selectin ligand interactions alters tumor protection by CD8 + T cells in FtDKO mice. Listeria monocytogenes-OVA (LM-OVA) infection evoked potent OVA-specific CD8 + T cells that proliferated and contracted at similar kinetics and phenotype in FtDKO and wild-type mice. Additionally, OVA-specific CD8 + T cells in both mouse strains exhibited similar phenotypic differentiation, in vivo cytolytic activity and IFN-\u3b3 expression. However, FtDKO mice succumbed to B16-OVA tumors significantly earlier than wild-type mice. In contrast, FtDKO mice evoked strong recall memory CD8 + T cell responses and protection to systemic LM-OVA re-challenge. The diminished tumor protection in FtDKO mice was not related to defective antigen presentation by dendritic cells or reduced proliferation of antigen-specific CD8 + T cells. However, WT or FtDKO OVA-specific CD8 + T cells showed significantly reduced ability to traffic to lymph nodes upon adoptive transfer into na\uefve FtDKO recipients. Furthermore, FtDKO OVA-specific CD8 + T cells displayed poor ability to infiltrate tumors growing in WT mice. These results reveal that selectin ligand expression on host endothelium as well CD8 + T cells may be important for their efficient and continued extravasation into peripheral tumors. \ua9 2012 Stark et al.Peer reviewed: YesNRC publication: Ye